Login / Signup

Low Disease Activity Early in the Course of Systemic Lupus Erythematosus.

Manuel Francisco Ugarte-GilGraciela S Alarcon
Published in: The Journal of rheumatology (2024)
In patients with systemic lupus erythematosus (SLE), remission and low disease activity (LDA) have been shown to be protective of damage accrual, mortality, and flares; they have also been shown to be associated with a better health-related quality of life. 1 However, the large majority of published studies include patients with long-standing disease.
Keyphrases